WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Singapore
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Regulatory

Open PDF
  • An Elite Antitrust and Competition Practice

    Hailed by Global Competition Review as “perhaps the best Antitrust and Competition practice for high-tech matters in the world,” Wilson Sonsini’s exceptional Antitrust and Competition practice group represents clients in high-stakes antitrust litigation, mergers, and criminal and civil investigation, in addition to providing valuable counseling on business strategy.

  • Expanded Healthcare and FDA Regulatory Practice

    Wilson Sonsini's newly expanded Regulatory practice includes attorneys experienced in helping clients with healthcare, FDA, and consumer product compliance.

  • CFIUS and Export Controls Teams Anchored by Former Government Officials

    Wilson Sonsini’s CFIUS and export controls teams include attorneys who have served in the U.S. government on CFIUS and the constituent agencies that enforce national security laws, including the Departments of Commerce, Defense, Homeland Security, and Justice; and the CIA.

  • A Highly Ranked Privacy and Cybersecurity Practice
    Wilson Sonsini's Privacy and Cybersecurity practice is consistently recognized by well-known ranking authorities such as Law360, Chambers USA, Chambers Global, Chambers Europe, and Legal 500.

Wilson Sonsini is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies from entrepreneurial start-ups to multibillion-dollar global corporations at every stage of development. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.

The firm has expanded its regulatory services to address the ongoing need clients have for advice concerning enforcement and oversight agencies, both in the U.S. and certain international markets. Our services include antitrust and competition; privacy and cybersecurity; FDA, healthcare, and consumer products; national security (export trade; CFIUS; and FCPA); and advising on other regulatory issues.

In this area, the firm's clients include companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, software and other sectors.

Overview

Wilson Sonsini is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies from entrepreneurial start-ups to multibillion-dollar global corporations at every stage of development. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.

The firm has expanded its regulatory services to address the ongoing need clients have for advice concerning enforcement and oversight agencies, both in the U.S. and certain international markets. Our services include antitrust and competition; privacy and cybersecurity; FDA, healthcare, and consumer products; national security (export trade; CFIUS; and FCPA); and advising on other regulatory issues.

In this area, the firm's clients include companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, software and other sectors.

Blog Posts
CMS Finalizes RPM and RTM Changes in CY 2027 Physician Fee Schedule
On November 9, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the Calendar Year 2027 Physician Fee Schedule final rule, finalizing significant changes to Medicare requirements for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM), effective January 1, 2027. This post summarizes the rule’s RPM and RTM provisions.
Blog Posts
EDPB Adopts Statement on Smart Glasses Under GDPR
On October 13, 2026, the European Data Protection Board adopted a Statement on Smart Glasses, setting out its preliminary views on how the EU GDPR applies to eyewear equipped with cameras, microphones, and AI features. Although not binding, the statement signals how EU data protection authorities are likely to approach smart glasses. This post examines how responsibility is allocated under the GDPR, the EDPB’s expectations on bystander transparency, consent, and technical safeguards, and other compliance considerations, as well as next steps for companies as more detailed guidance develops.
Blog Posts
FDA Issues Final Guidance on Drug Labeling Considerations for Prescription Drug Use-Related Software
On October 20, 2026, the U.S. Food and Drug Administration (FDA) issued final guidance, Regulatory Considerations for Prescription Drug Use-Related Software, describing how the agency intends to apply its existing drug labeling authorities to software disseminated by or on behalf of a drug sponsor. Although nonbinding, the guidance signals that the FDA will treat the output of such software as prescription drug labeling, whether or not the software is regulated as a device.
Blog Posts
FDA Seeks Input on Autonomous and Remotely Operated Medical Robots
The FDA released a discussion paper on evaluating the benefits and risks of robotic medical devices with autonomous functions or remote teleoperation. The FDA will discuss the paper at a hybrid public workshop on December 2 and 3, 2026, and is accepting public comments through January 5, 2027.
Alerts
Major EU Consumer Law Reform for Online Businesses: European Commission Proposes Digital Fairness Act
On November 11, 2026, the European Commission (EC) published its proposal for a Digital Fairness Act (DFA), which would significantly reform the European Union (EU) consumer protection framework and introduce new restrictions on addictive design, influencer marketing, manipulative practices, unfair personalization, and in-game spending. As proposed, the DFA would provide the EC with direct powers to investigate and impose fines of up to six percent of worldwide annual revenue.
News Articles
Wilson Sonsini Partners Sachin Kohli and Demian Ahn Contribute to Diligent’s Q4 GC Risk Index Report
Mergers & Acquisitions partner Sachin Kohli and Data, Privacy, and Cybersecurity partner Demian Ahn recently contributed to the Q4 edition of the General Counsel (GC) Risk Index report published by Diligent Institute. This report explores how legal leaders assess the current risk environment, what risks are driving those assessments, how AI governance is structured, how boards are preparing to oversee AI, and whether organizations are ready to respond to cyber events and related disclosure obligations.
View All
Insights
Blog Posts
CMS Finalizes RPM and RTM Changes in CY 2027 Physician Fee Schedule
On November 9, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the Calendar Year 2027 Physician Fee Schedule final rule, finalizing significant changes to Medicare requirements for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM), effective January 1, 2027. This post summarizes the rule’s RPM and RTM provisions.
Blog Posts
EDPB Adopts Statement on Smart Glasses Under GDPR
On October 13, 2026, the European Data Protection Board adopted a Statement on Smart Glasses, setting out its preliminary views on how the EU GDPR applies to eyewear equipped with cameras, microphones, and AI features. Although not binding, the statement signals how EU data protection authorities are likely to approach smart glasses. This post examines how responsibility is allocated under the GDPR, the EDPB’s expectations on bystander transparency, consent, and technical safeguards, and other compliance considerations, as well as next steps for companies as more detailed guidance develops.
Blog Posts
FDA Issues Final Guidance on Drug Labeling Considerations for Prescription Drug Use-Related Software
On October 20, 2026, the U.S. Food and Drug Administration (FDA) issued final guidance, Regulatory Considerations for Prescription Drug Use-Related Software, describing how the agency intends to apply its existing drug labeling authorities to software disseminated by or on behalf of a drug sponsor. Although nonbinding, the guidance signals that the FDA will treat the output of such software as prescription drug labeling, whether or not the software is regulated as a device.
Blog Posts
FDA Seeks Input on Autonomous and Remotely Operated Medical Robots
The FDA released a discussion paper on evaluating the benefits and risks of robotic medical devices with autonomous functions or remote teleoperation. The FDA will discuss the paper at a hybrid public workshop on December 2 and 3, 2026, and is accepting public comments through January 5, 2027.
Alerts
Major EU Consumer Law Reform for Online Businesses: European Commission Proposes Digital Fairness Act
On November 11, 2026, the European Commission (EC) published its proposal for a Digital Fairness Act (DFA), which would significantly reform the European Union (EU) consumer protection framework and introduce new restrictions on addictive design, influencer marketing, manipulative practices, unfair personalization, and in-game spending. As proposed, the DFA would provide the EC with direct powers to investigate and impose fines of up to six percent of worldwide annual revenue.
News Articles
Wilson Sonsini Partners Sachin Kohli and Demian Ahn Contribute to Diligent’s Q4 GC Risk Index Report
Mergers & Acquisitions partner Sachin Kohli and Data, Privacy, and Cybersecurity partner Demian Ahn recently contributed to the Q4 edition of the General Counsel (GC) Risk Index report published by Diligent Institute. This report explores how legal leaders assess the current risk environment, what risks are driving those assessments, how AI governance is structured, how boards are preparing to oversee AI, and whether organizations are ready to respond to cyber events and related disclosure obligations.
View All
Speaking Engagements
GCR Live: Global 2027
Jamillia Ferris, co-chair of Wilson Sonsini’s Antitrust and Competition practice, will moderate the session “Mergers: AI Deals Under the Microscope: When Does Collaboration Become a Merger?” at GCR Live: Global, alongside fellow panelists from private practice.
Speaking Engagements
Informa Connect's CompLaw: Pharma 2026
Wilson Sonsini Of Counsel Andrew Morrison joins the "Product Bundling: Competition Law Concerns" panel at CompLaw: Pharma, hosted by Informa Connect. Andrew is joined by Luca Arnaudo, Senior Officer at the Italian Competition Authority, and Andrea Bazzotti, European Legal Counsel at Ultragenyx Europe GmbH.
Affiliated Programs
The Competition Law & Artificial Intelligence Summit 2026, ThoughtLeaders4
Wilson Sonsini partner Jindrich Kloub is moderating the "Insights from EU Member State Regulators" session at The Competition Law & Artificial Intelligence Summit, hosted by ThoughtLeaders4. Jindrich is joined by Yann Guthmann, Head of the Digital Economy Unit at Autorité de la concurrence.
Speaking Engagements
How We Build NYC
On November 18, Wilson Sonsini partner Maneesha Mithal will speak at How We Build NYC: The Commercial, Policy, and Public Cases for Open Source AI, hosted by Responsible Innovation Labs. The speakers will discuss current regulations surrounding open-source AI models and the future regulatory landscape.
Speaking Engagements
IAPP Europe Data Protection Congress 2026
Wilson Sonsini is pleased to sponsor IAPP Europe Congress 2026. Partner Yann Padova and associate Roberto Yunquera Sehwani will speak as part of the conference, which takes place November 16–19 in Brussels. IAPP Congress 2026 is the leading conference for privacy, artificial intelligence governance, and cybersecurity law professionals looking to gain insight into the latest developments in data protection operations and regulations in Europe and beyond.
Affiliated Programs
Digital Markets & Competition Conference 2026
Maureen Ohlhausen, Wilson Sonsini partner and former FTC Acting Chairman, joins the “AI and Antitrust: Competition Challenges in an AI-Driven Economy” panel at the Digital Markets & Competition Conference, hosted by Concurrences and NYU Stern. Maureen is joined by fellow panelists from government and industry, with Trevor Wagener of the Computer & Communications Industry Association moderating.
View All
Events
Speaking Engagements
GCR Live: Global 2027
Jamillia Ferris, co-chair of Wilson Sonsini’s Antitrust and Competition practice, will moderate the session “Mergers: AI Deals Under the Microscope: When Does Collaboration Become a Merger?” at GCR Live: Global, alongside fellow panelists from private practice.
Speaking Engagements
Informa Connect's CompLaw: Pharma 2026
Wilson Sonsini Of Counsel Andrew Morrison joins the "Product Bundling: Competition Law Concerns" panel at CompLaw: Pharma, hosted by Informa Connect. Andrew is joined by Luca Arnaudo, Senior Officer at the Italian Competition Authority, and Andrea Bazzotti, European Legal Counsel at Ultragenyx Europe GmbH.
Affiliated Programs
The Competition Law & Artificial Intelligence Summit 2026, ThoughtLeaders4
Wilson Sonsini partner Jindrich Kloub is moderating the "Insights from EU Member State Regulators" session at The Competition Law & Artificial Intelligence Summit, hosted by ThoughtLeaders4. Jindrich is joined by Yann Guthmann, Head of the Digital Economy Unit at Autorité de la concurrence.
Speaking Engagements
How We Build NYC
On November 18, Wilson Sonsini partner Maneesha Mithal will speak at How We Build NYC: The Commercial, Policy, and Public Cases for Open Source AI, hosted by Responsible Innovation Labs. The speakers will discuss current regulations surrounding open-source AI models and the future regulatory landscape.
Speaking Engagements
IAPP Europe Data Protection Congress 2026
Wilson Sonsini is pleased to sponsor IAPP Europe Congress 2026. Partner Yann Padova and associate Roberto Yunquera Sehwani will speak as part of the conference, which takes place November 16–19 in Brussels. IAPP Congress 2026 is the leading conference for privacy, artificial intelligence governance, and cybersecurity law professionals looking to gain insight into the latest developments in data protection operations and regulations in Europe and beyond.
Affiliated Programs
Digital Markets & Competition Conference 2026
Maureen Ohlhausen, Wilson Sonsini partner and former FTC Acting Chairman, joins the “AI and Antitrust: Competition Challenges in an AI-Driven Economy” panel at the Digital Markets & Competition Conference, hosted by Concurrences and NYU Stern. Maureen is joined by fellow panelists from government and industry, with Trevor Wagener of the Computer & Communications Industry Association moderating.
View All
Josephine Aiello LeBeau
Partner
Washington, D.C.
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
  • National Security and Trade
View Profile
Mark Bass
Partner
Washington, D.C.
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings. 
  • Corporate
View Profile
Michael S. Casey
Partner
London
Mike Casey is a dual-qualified, Chambers-ranked (Band 1) partner in Wilson Sonsini Goodrich & Rosati’s London office. His practice focuses on advising clients on sanctions, export controls, anti-corruption, and anti-money laundering issues in investigations, counseling, and compliance matters. In addition, he regularly acts as a specialist in mergers, acquisitions, venture financings, lending arrangements, and other types of corporate transactions. He also frequently advises clients on the UK’s National Security and Investment Act and other foreign direct investment review regimes.

Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”

Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.

Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.

Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.

Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
  • National Security and Trade
View Profile
Jocelyn Chow
Partner
Hong Kong
Jocelyn Chow is a regulatory and compliance partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. With a focus on antitrust, national security, and international trade matters, Jocelyn advises multinational corporations on all aspects of antitrust law, global economic and trade sanctions, export controls, import controls, rules of origin, and foreign investment controls. She works with companies operating across numerous industrial sectors, including defense, bioscience, advanced engineering and technology, aviation, telecommunications and broadcasting, and financial services.
  • Regulatory
View Profile
Jodi Daniel
Partner
Washington, D.C.
Jodi Daniel is a nationally recognized leader in digital health law and policy, trusted by health care organizations and technology innovators to navigate the complex and dynamic regulatory landscape of digital health and wellness. With over 30 years of experience in healthcare innovation—including 15 years as a lawyer and senior policymaker at the U.S. Department of Health and Human Services (HHS)—Jodi leverages her extensive experience in digital health and health data to deliver strategic, practical advice to clients engaged in groundbreaking products and services that raise novel legal, policy, and ethical issues.
  • Regulatory
View Profile
Mark R. Fitzgerald
Partner
Boston
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
  • Corporate
View Profile
Joshua F. Gruenspecht
Partner
Washington, D.C.
Joshua advises domestic and foreign investors, funds, established companies and startups in regulatory, investigative, and enforcement matters.
  • National Security and Trade
View Profile
Jahna Hartwig
Partner
Washington, D.C.
Jahna Hartwig is a partner at Wilson Sonsini Goodrich & Rosati, where she advises domestic and foreign companies on compliance with international trade laws.
  • Regulatory
View Profile
Stephen R. Heifetz
Partner
Washington, D.C.

Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.

  • National Security and Trade
View Profile
Sanil Khatri
Partner
Singapore
Sanil Khatri is a partner in the Singapore office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s data, privacy, and cybersecurity practice. Sanil advises multinational companies and high-growth start-ups on the legal issues where data, technology, and regulation intersect across Asia Pacific (APAC).
  • Data, Privacy, and Cybersecurity
View Profile
View All
People
Josephine Aiello LeBeau
Partner
Washington, D.C.
Josephine focuses on matters related to compliance and enforcement of U.S. export control and sanctions.
  • National Security and Trade
View Profile
Mark Bass
Partner
Washington, D.C.
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings. 
  • Corporate
View Profile
Michael S. Casey
Partner
London
Mike Casey is a dual-qualified, Chambers-ranked (Band 1) partner in Wilson Sonsini Goodrich & Rosati’s London office. His practice focuses on advising clients on sanctions, export controls, anti-corruption, and anti-money laundering issues in investigations, counseling, and compliance matters. In addition, he regularly acts as a specialist in mergers, acquisitions, venture financings, lending arrangements, and other types of corporate transactions. He also frequently advises clients on the UK’s National Security and Investment Act and other foreign direct investment review regimes.

Chambers UK noted that Mike is “a one-stop shop for global sanctions advice” who is “very responsive with his provision of highly commercial advice.” The publication also described Mike as “one of the most experienced practitioners in the market” who “understands and takes into consideration any necessary complexities and understands the importance of commerciality when giving recommendations.”

Mike has led numerous internal and government-initiated investigations involving potential violations of sanctions, export controls, anti-money laundering laws, anti-bribery laws, and fraud laws throughout the world. He has also represented individuals in pending and threatened litigation.

Mike regularly advises clients on a wide range of compliance issues. He works with clients to develop and implement state-of-the-art compliance programs, including corporate policies, training programs, and third-party procedures. Further, Mike assists clients with carrying out due diligence for many types of corporate transactions. He has successfully guided dozens of investors and companies through the NSI Act review process.

Prior to joining Wilson Sonsini, Mike was a partner in the London office of Kirkland & Ellis.

Mike is the author of Sanctions Enforcement and Compliance: A Practitioner’s Guide to OFAC, a treatise published by Bloomberg BNA. Additionally, leading legal publications have published more than 45 of his articles. He has been quoted in numerous publications, including The Wall Street Journal, The New York Times, and Global Investigations Review.
  • National Security and Trade
View Profile
Jocelyn Chow
Partner
Hong Kong
Jocelyn Chow is a regulatory and compliance partner in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. With a focus on antitrust, national security, and international trade matters, Jocelyn advises multinational corporations on all aspects of antitrust law, global economic and trade sanctions, export controls, import controls, rules of origin, and foreign investment controls. She works with companies operating across numerous industrial sectors, including defense, bioscience, advanced engineering and technology, aviation, telecommunications and broadcasting, and financial services.
  • Regulatory
View Profile
Jodi Daniel
Partner
Washington, D.C.
Jodi Daniel is a nationally recognized leader in digital health law and policy, trusted by health care organizations and technology innovators to navigate the complex and dynamic regulatory landscape of digital health and wellness. With over 30 years of experience in healthcare innovation—including 15 years as a lawyer and senior policymaker at the U.S. Department of Health and Human Services (HHS)—Jodi leverages her extensive experience in digital health and health data to deliver strategic, practical advice to clients engaged in groundbreaking products and services that raise novel legal, policy, and ethical issues.
  • Regulatory
View Profile
Mark R. Fitzgerald
Partner
Boston
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
  • Corporate
View Profile
Joshua F. Gruenspecht
Partner
Washington, D.C.
Joshua advises domestic and foreign investors, funds, established companies and startups in regulatory, investigative, and enforcement matters.
  • National Security and Trade
View Profile
Jahna Hartwig
Partner
Washington, D.C.
Jahna Hartwig is a partner at Wilson Sonsini Goodrich & Rosati, where she advises domestic and foreign companies on compliance with international trade laws.
  • Regulatory
View Profile
Stephen R. Heifetz
Partner
Washington, D.C.

Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.

  • National Security and Trade
View Profile
Sanil Khatri
Partner
Singapore
Sanil Khatri is a partner in the Singapore office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s data, privacy, and cybersecurity practice. Sanil advises multinational companies and high-growth start-ups on the legal issues where data, technology, and regulation intersect across Asia Pacific (APAC).
  • Data, Privacy, and Cybersecurity
View Profile
View All
Related Practices
  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the United States (CFIUS)
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Healthcare and FDA Regulatory
  • Federal Trade Commission
  • Fintech and Financial Services
  • National Security and Trade
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance
Recent Insights
Blog Posts
CMS Finalizes RPM and RTM Changes in CY 2027 Physician Fee Schedule
On November 9, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the Calendar Year 2027 Physician Fee Schedule final rule, finalizing significant changes to Medicare requirements for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM), effective January 1, 2027. This post summarizes the rule’s RPM and RTM provisions.
Learn More
Blog Posts
EDPB Adopts Statement on Smart Glasses Under GDPR
On October 13, 2026, the European Data Protection Board adopted a Statement on Smart Glasses, setting out its preliminary views on how the EU GDPR applies to eyewear equipped with cameras, microphones, and AI features. Although not binding, the statement signals how EU data protection authorities are likely to approach smart glasses. This post examines how responsibility is allocated under the GDPR, the EDPB’s expectations on bystander transparency, consent, and technical safeguards, and other compliance considerations, as well as next steps for companies as more detailed guidance develops.
Learn More
View All
Recent Events
Speaking Engagements
GCR Live: Global 2027
Jamillia Ferris, co-chair of Wilson Sonsini’s Antitrust and Competition practice, will moderate the session “Mergers: AI Deals Under the Microscope: When Does Collaboration Become a Merger?” at GCR Live: Global, alongside fellow panelists from private practice.
Learn More
Speaking Engagements
Informa Connect's CompLaw: Pharma 2026
Wilson Sonsini Of Counsel Andrew Morrison joins the "Product Bundling: Competition Law Concerns" panel at CompLaw: Pharma, hosted by Informa Connect. Andrew is joined by Luca Arnaudo, Senior Officer at the Italian Competition Authority, and Andrea Bazzotti, European Legal Counsel at Ultragenyx Europe GmbH.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.